Su Liang, Yang Zhao-Tian, Qu Hua, Luo Cheng-Long, Yuan Guo-Xing, Wu Jie, Jiao Yong-Zheng
Guang'anmen Hospital, China Academy of Chinese Medical Sciences, Beijing, China.
The Affiliated Hospital of Shaanxi University of Chinese Medicine, Xianyang, China.
Sex Med Rev. 2022 Oct;10(4):754-763. doi: 10.1016/j.sxmr.2022.01.002. Epub 2022 Mar 1.
In Erectile dysfunction (ED) patients, phosphodiesterase type 5 (PDE5) inhibitors are considered as the first-line therapy. However, 30-50% of ED patients fail to follow this therapeutic option because of adverse events, lack of efficacy, or drug costs. Antioxidant supplementation is widely applied in clinical practice and viewed as a potential therapeutic option for ED. Therefore, it is attractive to assess the effect of antioxidants supplementation on ED patients.
To evaluate the effects of antioxidants supplementation on ED.
Published randomized controlled trials of antioxidants in ED were searched in the PubMed, Embase, and Cochrane Library databases from inception to October 3, 2021. Meta-analyses were carried out using a random-effects model. The results were presented as standard mean differences (SMDs) with their 95% confidence intervals (CIs).
Eighteen studies with 1,331 ED patients were included in the study. Compared with placebo, antioxidants alone treatment showed a statistical increase in International Index of Erectile Function (IIEF) score (SMD = 1.93; 95% CI: 0.15, 3.72; P = .034). Compared with placebo, antioxidants compound treatment elicited a significant increase in IIEF score (SMD = 2.74; 95% CI: 1.67, 3.81; P < .001) as well as sexual satisfaction score (SMD = 1.61; 95% CI: 0.63, 2.59; P = .001). Compared with the PDE5 inhibitors alone, combination of PDE5 inhibitors and antioxidants showed a significant increase in IIEF score (SMD = 1.1; 95% CI: 0.51, 1.68; P < .001) and sexual satisfaction score (SMD = 1.28; 95% CI: 0.06, 2.51; P = .04).
This study found that the effect of antioxidant alone treatment on ED may be limited. However, antioxidant compound treatment, as well as combination of PDE5 inhibitors and antioxidants, were associated with improved ED, and can be considered as an accessary therapeutic option for ED. Su L, Yang Z, Qu H, et al. Effect of Antioxidants Supplementation on Erectile Dysfunction: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Sex Med Rev 2022;10:754-763.
在勃起功能障碍(ED)患者中,5型磷酸二酯酶(PDE5)抑制剂被视为一线治疗方法。然而,30%-50%的ED患者由于不良事件、疗效不佳或药物成本等原因未能采用这种治疗方案。抗氧化剂补充剂在临床实践中广泛应用,被视为ED的一种潜在治疗选择。因此,评估抗氧化剂补充剂对ED患者的影响很有吸引力。
评估抗氧化剂补充剂对ED的影响。
在PubMed、Embase和Cochrane图书馆数据库中检索从创刊至2021年10月3日发表的关于抗氧化剂治疗ED的随机对照试验。采用随机效应模型进行荟萃分析。结果以标准平均差(SMD)及其95%置信区间(CI)表示。
该研究纳入了18项研究,共1331例ED患者。与安慰剂相比,单独使用抗氧化剂治疗使国际勃起功能指数(IIEF)评分有统计学意义的增加(SMD = 1.93;95%CI:0.15,3.72;P = 0.034)。与安慰剂相比,抗氧化剂复合治疗使IIEF评分显著增加(SMD = 2.74;95%CI:1.67,3.81;P < 0.001)以及性满意度评分增加(SMD = 1.61;95%CI:0.63,2.59;P = 0.001)。与单独使用PDE5抑制剂相比,PDE5抑制剂与抗氧化剂联合使用使IIEF评分显著增加(SMD = 1.1;95%CI:0.51,1.68;P < 0.001)和性满意度评分增加(SMD = 1.28;95%CI:0.06,2.51;P = 0.04)。
本研究发现单独使用抗氧化剂治疗ED的效果可能有限。然而,抗氧化剂复合治疗以及PDE5抑制剂与抗氧化剂联合使用均与ED改善相关,可被视为ED的一种辅助治疗选择。苏L,杨Z,曲H等。抗氧化剂补充对勃起功能障碍的影响:一项随机对照试验的系统评价和荟萃分析。性医学评论2022;10:754 - 763。